Mixed Dyslipidemia
📧 Sign up to get email alerts when something new happens for Mixed Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-04-12FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Lipitor (atorvastatin calcium) submitted by Viatris Specialty LLC.
-
FDA approval · 2019-04-02FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC.
-
FDA approval · 2019-03-28FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2019-02-11FDA Approved: FENOFIBRATE — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's original application for a generic fenofibrate product used to treat hyperlipidemia, hypertriglyceridemia, …
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia [Phase 3]
Phase 3 trial evaluating evolocumab in combination with statin therapy in adults with diabetes and hyperlipidemia or mixed dyslipidemia; com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-12-13FDA Approved: GEMFIBROZIL — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved a supplemental application for gemfibrozil filed by Cadila Pharmaceuticals Limited, changing the labeling of this generic lipid…
-
FDA approval · 2018-11-07FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for fenofibrate from Lupin Pharmaceuticals, Inc.
-
FDA approval · 2018-11-07FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Fenofibric Acid from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia [Phase 3]
Phase 3 trial evaluating evolocumab in diabetic adults with hypercholesterolemia or mixed dyslipidemia has completed with results posted.
-
FDA approval · 2018-08-28FDA Approved: FENOFIBRATE — Original Application (Solco Healthcare US, LLC)
FDA approved the original application for fenofibrate (generic) from Solco Healthcare US, LLC, authorizing its use for certain lipid disorde…
-
FDA approval · 2018-08-17FDA Approved: FENOFIBRATE — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's original Abbreviated New Drug Application for fenofibrate, enabling marketing of a generic fenofibrate pr…
-
FDA approval · 2018-07-20FDA Approved: FENOFIBRATE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s generic fenofibrate (FENOFIBRATE) under an Original Abbreviated New Drug Application.
-
FDA approval · 2018-06-26FDA Approved: FENOFIBRATE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Fenofibrate's original application from Torrent Pharmaceuticals Limited under ANDA210782, making a generic option available for…
-
FDA approval · 2018-05-21FDA Approved: EZETIMIBE — Supplemental Application (Ascend Laboratories, LLC)
FDA has approved a supplemental application for ezetimibe from Ascend Laboratories, LLC, authorizing continued marketing under the ANDA.
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate submitted by Lupin Pharmaceuticals, Inc. The notice indicates an updated approval fo…
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.,)
FDA approved a supplemental application for fenofibrate filed by Cipla USA Inc. under ANDA207378.
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC, approving a generic fenofibrate product.
-
FDA approval · 2018-05-18FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc.
-
FDA label_change · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for fenofibrate from Glenmark Pharmaceuticals Inc., USA, resulting in changes to the drug’s labe…
-
FDA approval · 2018-04-30FDA Approved: FENOFIBRATE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' generic fenofibrate under an Original Application (ANDA 209504).
-
FDA approval · 2018-04-20FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2018-02-09FDA Approved: FENOFIBRATE — Original Application (AvKARE)
FDA approved AvKARE's generic fenofibrate under an Original Application (ANDA 209951).
-
FDA approval · 2017-12-19FDA Approved: FENOFIBRATE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' original application for fenofibrate, authorizing the marketing of a generic fenofibrate product.
-
CLINICAL_TRIALS withdrawal · 2017-12-02Clinical Trial Update: Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects [Phase 3]
Pfizer has withdrawn the Phase 3 trial evaluating bococizumab for lipid lowering in Asian subjects with primary hyperlipidemia or mixed dysl…
-
FDA approval · 2017-11-22FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved the original application for rosuvastatin calcium (generic rosuvastatin calcium) from Quallent Pharmaceuticals Health LLC. The …